fbpx

Join us for our upcoming webcast: Orthovoltage Radiotherapy for Veterinary Oncology with Dr. Olivier Keravel on June 30.

X-Rays Minibeam Radiation Therapy at a Conventional Irradiator: Pilot Evaluation in F98-Glioma Bearing Rats and Dose Calculations in a Human Phantom

Publication: X-Rays Minibeam Radiation Therapy at a Conventional Irradiator: Pilot Evaluation in F98-Glioma Bearing Rats and Dose Calculations in a Human Phantom Authors: Sotiropoulos, Marios Brisebard, Elise Le Dudal, Marine Jouvion, Gregory Juchaux, Marjorie Crépin,...

Synergistic Anticancer Activity of N-Hydroxy-7-(2-Naphthylthio) Heptanomide, Sorafenib, and Radiation Therapy in Patient-Derived Anaplastic Thyroid Cancer Models

Publication: Synergistic Anticancer Activity of N-Hydroxy-7-(2-Naphthylthio) Heptanomide, Sorafenib, and Radiation Therapy in Patient-Derived Anaplastic Thyroid Cancer Models Authors: Yun, Hyeok Jun, Kim, Hee Jun Kim, Jungmin Kim, Sang Yong Chang, Hang-Seok Park,...

Radiotherapy Delivered before CDK4/6 Inhibitors Mediates Superior Therapeutic Effects in ER+ Breast Cancer

Study: Radiotherapy Delivered before CDK4/6 Inhibitors Mediates Superior Therapeutic Effects in ER+ Breast Cancer Authors: Petroni, Giulia Buqué, Aitziber Yamazaki, Takahiro Bloy, Norma Di Liberto, Maurizio Chen-iang, Selina Formenti, Silvia C. Galluzzi, Lorenzo...
X-Rays Minibeam Radiation Therapy at a Conventional Irradiator: Pilot Evaluation in F98-Glioma Bearing Rats and Dose Calculations in a Human Phantom

X-Rays Minibeam Radiation Therapy at a Conventional Irradiator: Pilot Evaluation in F98-Glioma Bearing Rats and Dose Calculations in a Human Phantom

Synergistic Anticancer Activity of N-Hydroxy-7-(2-Naphthylthio) Heptanomide, Sorafenib, and Radiation Therapy in Patient-Derived Anaplastic Thyroid Cancer Models

Synergistic Anticancer Activity of N-Hydroxy-7-(2-Naphthylthio) Heptanomide, Sorafenib, and Radiation Therapy in Patient-Derived Anaplastic Thyroid Cancer Models

Radiotherapy Delivered before CDK4/6 Inhibitors Mediates Superior Therapeutic Effects in ER+ Breast Cancer

Radiotherapy Delivered before CDK4/6 Inhibitors Mediates Superior Therapeutic Effects in ER+ Breast Cancer

Explore Our Resources

Presentations

Case Studies

Xstrahl 300 used in Lower Leg Lesion Treatment

Xstrahl 300 used in Lower Leg Lesion Treatment

Xstrahl in Action: Xstrahl 300 Used in Treatment of Paget’s Disease

Xstrahl in Action: Xstrahl 300 Used in Treatment of Paget’s Disease

Xstrahl in Action: Xstrahl 300 used in Definitive Radiotherapy

Xstrahl in Action: Xstrahl 300 used in Definitive Radiotherapy

Office-Based Surface Radiotherapy for the Dermatology Clinic: A Two-Case Study

Office-Based Surface Radiotherapy for the Dermatology Clinic: A Two-Case Study

Simple Treatment for SCC and BCC Lesions

Simple Treatment for SCC and BCC Lesions

View More Resources

User Spotlights

Spotlight on Precision Dermatology: Texas Physicians Work Together to Expand NMSC Treatment Options

Spotlight on Precision Dermatology: Texas Physicians Work Together to Expand NMSC Treatment Options

SARRP Research Spotlight: Dr. George Wilson

SARRP Research Spotlight: Dr. George Wilson

SARRP Research Spotlight: Dr. Chandan Guha

SARRP Research Spotlight: Dr. Chandan Guha

Glioblastoma, Pancreatic and Rectal Cancer Research at University of Glasgow

Glioblastoma, Pancreatic and Rectal Cancer Research at University of Glasgow

Our Videos

Radiation Therapy During COVID

Radiation Therapy During COVID

The Future of Skin Cancer Treatment

The Future of Skin Cancer Treatment

A Medical Physicist’s Perspective on Superficial & Orthovoltage Radiotherapy

A Medical Physicist’s Perspective on Superficial & Orthovoltage Radiotherapy

About Us

Find out more about our mission to expand the use of radiation therapy to improve patient care and outcomes

Radiation for Skin Cancer

Treat basal cell carcinoma and squamous cell carcinoma with low-energy radiotherapy.